By Ben Glickman Shares of Arcturus Therapeutics Holdings fell after the company's loss widened more than expected in the second quarter. The stock was down.
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) saw a large growth in short interest in July. As of July 15th, there was short interest totalling 3,630,000 shares, a growth of 9.0% from the June 30th total of 3,330,000 shares. Currently, 15.0% of the shares of the company are sold short. Based on an […]